Levotiroxina Doc

Levothyroxine, the active ingredient in Levotiroxina Doc, is a thyroid hormone presented as an oral tablet for systemic use. It is used to treat hypothyroidism and to provide hormone replacement after thyroidectomy or in patients with goiter.

GNH USA supplies Levotiroxina Doc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Clients benefit from reliable logistics and comprehensive documentation for import compliance.

Levotiroxina Doc is indicated for conditions involving deficient thyroid hormone production.

- Hypothyroidism: restores normal thyroid hormone levels to alleviate fatigue, weight gain and cold intolerance. - Post‑thyroidectomy hormone replacement: provides necessary thyroxine after surgical removal of the thyroid gland. - Goiter: reduces gland enlargement by normalizing circulating thyroid hormone.

Levotiroxina Doc may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Palpitations or rapid heartbeat - Headache - Insomnia

Serious or Rare Side Effects: - Cardiac arrhythmias (e.g., atrial fibrillation) - Severe bone loss leading to osteoporosis - Allergic reactions such as rash or angioedema

When prescribing Levotiroxina Doc, clinicians should consider several safety measures.

- Dose adjustment in elderly: start with lower dose and titrate cautiously. - Cardiovascular disease monitoring: assess for angina or arrhythmias before and during therapy. - Adrenal insufficiency caution: ensure adequate glucocorticoid replacement before initiating levothyroxine. - Pregnancy considerations: use the lowest effective dose and monitor thyroid function closely. - Concomitant medication review: evaluate for agents that may alter absorption or metabolism. - Store at ambient temperature: keep tablets in original container, protect from moisture and light.

Levotiroxina Doc can interact with several medicines, requiring attention to timing and monitoring.

Major Interactions (Avoid): - Calcium carbonate or calcium supplements: significantly reduce levothyroxine absorption. - Iron salts (ferrous sulfate): impair absorption when taken concurrently. - Sucralfate or aluminum/magnesium antacids: bind levothyroxine and decrease bioavailability.

Moderate Interactions (Monitor Closely): - Amiodarone: may alter thyroid hormone levels and require dose adjustment. - Anticonvulsants (phenytoin, carbamazepine): increase metabolism leading to reduced efficacy. - Rifampin: enhances hepatic clearance, potentially necessitating higher dose.